Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Costs for treatment of HIV

The University of Hasselt and the AIDS Reference Centre of Ghent University Hospital calculated that the treatment for people infected with HIV in…


Galapagos thinks big

Galapagos, the Mechelen biotech company, quit its inflammation alliance with Janssen under mutual agreement. Galapagos regained the proprietary ri…


Mithra to become the new Omega Pharma?

Businessman Marc Coucke has invested 40 million euros in the Liège pharmaceutical company Mithra. Coucke is now the second largest shareholder, be…

POPULAR TAGS

Cancer Specialist IBA shines after new contract in Florida

Written by DS on in the category quick facts with the tags .


IBA (Louvain-La-Neuve), a specialist in proton therapy for cancer treatment, saw it’s stock rise from 7.3% to 23.90 euros. The Walloon company netted an American contract of 74 million euros in Florida for the construction and maintenance of a radiotherapy center.

KBC Securities analyst Jan De Kerpel maintains its ‘buy’-advice and targets a price of 27 euros. IBA recently missed out on some European contracts at expense of rival Varian. It is interesting to see that the Americans now chose IBA based on experience in proton therapy, while for hospitals in the UK and Denmark, the price was decisive.

The Walloon cancer specialist showed off last week with impressive results and an optimistic outlook. With proton therapy, cancer cells can be precisely irradiated up to a millimeter.

Read more about: .

RELATED ARTICLES
Costs for treatment of HIV

The University of Hasselt and the AIDS Reference Centre of Ghent University Hospital calculated that the treatment for people infected with HIV in…


Galapagos thinks big

Galapagos, the Mechelen biotech company, quit its inflammation alliance with Janssen under mutual agreement. Galapagos regained the proprietary ri…


Mithra to become the new Omega Pharma?

Businessman Marc Coucke has invested 40 million euros in the Liège pharmaceutical company Mithra. Coucke is now the second largest shareholder, be…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

GSK Flanders.bio Turnstone UGent Janssen KU Leuven Itera Life Science Biowin V-Bio Ventures XpandInnovation

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.